Lynch Thomas G 4
4 · Evofem Biosciences, Inc. · Filed Jul 3, 2018
Insider Transaction Report
Form 4
Lynch Thomas G
Director
Transactions
- Exercise/Conversion
Common Stock
2018-07-02+75,000→ 75,000 total - Award
Restricted Stock Units
2018-07-02+75,000→ 75,000 total→ Common Stock (75,000 underlying) - Exercise/Conversion
Restricted Stock Units
2018-07-02−75,000→ 0 total→ Common Stock (75,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units were granted in consideration for certain consulting services provided to the Issuer in connection with the consulting agreement between Mr. Lynch and the Issuer dated April 1, 2016.
- [F2]The restricted stock units vested in full on July 2, 2018.